Based on our results we propose that inhibition of PPM1D may represent a promising strategy for improving efficacy of 5-FU in colon cancer treatment, especially in patients with MMR-deficient tumors located in caecum and ascending colon. Here, MRC1 is linked to colonic neoplasm.